No Widgets found in the Sidebar
Midi Health collaborates with Neurotrack to address cognitive issues during menopause

In a recent collaboration, Midi Health, a clinic that specializes in midlife women’s health, has partnered with Neurotrack, a digital cognitive assessment company. This partnership allows Midi Health clinicians to provide patients with a quick Neurotrack cognitive screening that can be completed on a smartphone, tablet, or computer in just three minutes. In comparison to traditional screenings that can take up to 20 minutes.

Chief Medical Officer Kathleen Jordan emphasizes that brain fog during menopause is common but it does not necessarily indicate a higher risk of dementia. However, for some women, the screening could help detect early signs of dementia which benefit from early treatment. Patients who receive low scores on the Neurotrack screening will be referred to providers for a more detailed evaluation.

Midi Health recently secured $25 million in Series A funding to expand access to its services nationwide and has received support from Google Ventures, Operator Collective, Felicis and others. Meanwhile Neurotrack based in Silicon Valley raised $10 million in 2022 and has partnered with insurance provider Nationwide to simplify the long-term care underwriting process. Their cognitive screening process has significantly reduced the time needed for evaluations making it more efficient and accessible for patients.

By Samantha Jones

As a dedicated content writer at, I bring a unique blend of creativity and precision to my work. With a passion for storytelling and a keen eye for detail, I strive to craft engaging and informative articles that captivate our readers. From breaking news to thought-provoking features, I am committed to delivering content that resonates with our audience and keeps them coming back for more. Join me on this exciting journey as we explore the ever-evolving world of news and information together.

Leave a Reply